EVMN Evommune, Inc.: institutional ownership and insider trading
115 funds reported holding $519M of Evommune, Inc. in their latest 13F filings; in Q2 2026 funds net bought $31.3M, with 42 new positions and 17 funds selling out; over the last 12 months insiders bought $70.2M and sold $2.28M on the open market; over its last four quarters it reported revenue of $10.0M and net income of −$94.7M.
EVMN revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$32.2M, EPS -0.89
- Quarter ended Mar 31, 2026: revenue $0, net income −$21.7M, EPS -0.64
- Quarter ended Dec 31, 2025: revenue $0, net income −$28.3M, EPS 15.13
- Quarter ended Sep 30, 2025: revenue $10.0M, net income −$12.5M, EPS -8.07
Famous investors holding EVMN
- Ken Griffin (Citadel Advisors): $637K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $339K, 0.0% of the portfolio
Largest institutional holders of EVMN
- EQT Fund Management S.a r.l. — $70.3M
- RA CAPITAL MANAGEMENT, L.P. — $46.4M
- SymBiosis Capital Partners, LLC — $29.4M
- PRICE T ROWE ASSOCIATES INC /MD/ — $25.8M
- Pivotal bioVenture Partners Investment Advisor LLC — $25.6M
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $23.4M
- JANUS HENDERSON GROUP PLC (JHG) — $20.6M
- RTW INVESTMENTS, LP — $20.0M
- Nan Fung Group Holdings Ltd — $19.2M
- Point72 Asset Management, L.P. — $19.1M
Recent EVMN insider trades
- Jul 8, 2026: Carver Kyle bought 1,000 shares ($13.3K)
- Jul 7, 2026: Kirsch Arthur S bought 10,000 shares ($133K)
- Jun 22, 2026: Pena Luis C. sold 7,438 shares ($169K)
- Jun 22, 2026: Drew Janice Suzann sold 20,000 shares ($453K)
5%+ owners
- T. Rowe Price Associates, Inc.: 5.4% (Schedule 13G, filed Aug 14, 2026)
- Point72 Asset Management, L.P.: 5.3% (Schedule 13G, filed Jul 16, 2026)
Who owns the most EVMN stock?
The largest institutional holders of Evommune, Inc. in the latest 13F filings are EQT Fund Management S.a r.l. ($70.3M), RA CAPITAL MANAGEMENT, L.P. ($46.4M), SymBiosis Capital Partners, LLC ($29.4M).
Are insiders buying or selling EVMN?
Over the last 12 months insiders bought $70.2M and sold $2.28M of Evommune, Inc. stock on the open market (SEC Form 4).
Which famous investors own EVMN?
Ken Griffin, Two Sigma.
What was EVMN's revenue last quarter?
Evommune, Inc. reported revenue of $0 for the quarter ended June 30, 2026, with net income of −$32.2M.
Which ETFs hold EVMN?
1 ETFs and mutual funds hold it among their top 100 positions, including ETAHX.